2'-Deoxycytidine - CAS 951-77-9
Catalog: |
BB041635 |
Product Name: |
2'-Deoxycytidine |
CAS: |
951-77-9 |
Synonyms: |
deoxycytidine; dCYD |
IUPAC Name: | 4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
Description: | A deoxyribonucleoside as Eg5 kinesin modulator with antiproliferative and apoptosis-inducing activity. |
Molecular Weight: | 227.22 |
Molecular Formula: | C9H13N3O4 |
Canonical SMILES: | C1C(C(OC1N2C=CC(=NC2=O)N)CO)O |
InChI: | InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1 |
InChI Key: | CKTSBUTUHBMZGZ-SHYZEUOFSA-N |
Boiling Point: | 497.6 °C at 760 mmHg |
Melting Point: | 209-211 °C |
Flash Point: | 254.8±31.5 °C |
Purity: | ≥ 98 % by HPLC |
Density: | 1.73 g/cm3 |
Solubility: | Soluble in water |
Appearance: | White to off-white powder |
Storage: | Store at 2-8 °C (under dark) |
LogP: | -1.01690 |
Vapor Pressure: | 0.0±2.9 mmHg at 25°C |
Publication Number | Title | Priority Date |
CN-113461743-A | 6-methylthioethyl purine-2' -deoxynucleoside and preparation method and application thereof | 20210709 |
CN-113373130-A | Cas12 protein, gene editing system containing Cas12 protein and application | 20210531 |
CN-113267557-A | Application of lignin as MALDI matrix in detection of small molecular substances | 20210427 |
CN-113189066-A | Bionic nano probe and preparation method and application thereof | 20210426 |
CN-112979721-A | Preparation method of high-purity antitumor drug troflurocytidine | 20210329 |
PMID | Publication Date | Title | Journal |
32603666 | 20201001 | Pharmacokinetics of gemcitabine and its amino acid ester prodrug following intravenous and oral administrations in mice | Biochemical pharmacology |
32042099 | 20200801 | Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis | Cell death and differentiation |
30191986 | 20190401 | Arsenic induces fibrogenic changes in human kidney epithelial cells potentially through epigenetic alterations in DNA methylation | Journal of cellular physiology |
30612929 | 20190201 | KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective study | Hepatobiliary & pancreatic diseases international : HBPD INT |
30844808 | 20190101 | A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer | Oncology |
Complexity: | 355 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 3 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 227.090607 |
Formal Charge: | 0 |
Heavy Atom Count: | 16 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 3 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 227.0906059 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 108 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -1.8 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Pyrimidines
Customers Also Viewed
-
[169689-05-8]
1S,2S-DHAC-Phenyl Trost Ligand
-
[875573-66-3]
Estra-1,3,5(10)-triene-3,17-diol,7-(9-bromononyl)-,17-acetate,(7a,17b)-
-
[30879-49-3]
2'-Nitro-5'-hydroxyacetophenone
-
[104517-96-6]
Ioversol related compound B
-
[433335-00-3]
N-Boc-(tosyl)methylamine
-
[1866059-82-6]
1,1,2,2-Tetrafluoro-3-methylsulfonylpropane
INDUSTRY LEADERS TRUST OUR PRODUCTS